DE
NVO

Diversified Enterprises’s Novo Nordisk NVO Stock Holding History

Diversified Enterprises’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446K Buy
9,295
+1,382
+17% +$59.4K 0.02% 261
2026
Q1 		$291K Buy
7,913
+11
+0.1% +$521 0.02% 326
2025
Q4 		$402K Buy
7,902
+1,386
+21% +$70.9K 0.02% 249
2025
Q3 		$362K Sell
6,516
-2,191
-25% -$128K 0.02% 209
2025
Q2 		$601K Buy
8,707
+638
+8% +$43.4K 0.04% 140
2025
Q1 		$560K Buy
8,069
+1,681
+26% +$139K 0.05% 148
2024
Q4 		$549K Buy
6,388
+172
+3% +$18.6K 0.05% 120
2024
Q3 		$740K Buy
+6,216
New +$829K 0.08% 94

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Diversified Enterprises's NVO Position: Q2 2026 in Review

Diversified Enterprises increased its Novo Nordisk (NVO) stake by 17% in Q2 2026, buying an estimated $59.4K and bringing the position to 9,295 shares worth $446K. The position accounts for 0.02% of the portfolio, ranked #261.

Diversified Enterprises first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $740K in Q3 2024. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Diversified Enterprises held 9,295 shares of Novo Nordisk worth $446K as of Q2 2026.
  • Diversified Enterprises bought 1,382 Novo Nordisk shares in Q2 2026, an estimated $59.4K.
  • Novo Nordisk made up 0.02% of Diversified Enterprises's portfolio in Q2 2026, its #261 holding.
  • Diversified Enterprises first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
  • Diversified Enterprises's Novo Nordisk position peaked at $740K in Q3 2024.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.